Akèy › Maladi Nèwolojik › Kansas
Etid klinik pou Maladi Nèwolojik nan Kansas
3 etid pou Maladi Nèwolojik ap chèche patisipan nan sit nan Kansas.
Tèks ofisyèl etid la (Anglè)
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- The University of Kansas - Clinical Research Center, Fairway
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595Product Surveillance Registry
- Kansas City
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #041, Overland Park
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.